Sarcopenia and muscle loss in multiple sclerosis patients
Part of Brain & nervous system, Immune system & allergy clinical trials.
This study looks at muscle loss (sarcopenia) in people with multiple sclerosis. It aims to understand what factors are linked to muscle loss, which could help improve care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You have been diagnosed with multiple sclerosis by a neurologist.
- You have not had an MS attack in the last 3 months.
- You can still walk (even if you need a cane or walker).
- You are willing to give consent to join the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study examines how often muscle loss occurs in people with knee arthritis and what factors contribute to it. Understanding this connection may help doctors better care for arthritis patients.
This study looks at how loss of muscle strength or mass (sarcopenia) relates to advanced liver disease. It may help doctors understand which patients are at higher risk and could guide future care choices.
This study looks at muscle changes in people with or at risk for sarcopenia (age-related muscle loss). It aims to find better ways to detect and manage sarcopenia using simple tests like muscle strength and body composition measurements.
This trial studies whether a structured exercise and nutrition program can improve muscle health in older adults with (pre)sarcopenia, especially those who may have slower walking or reduced strength. It also checks safety by excluding people with unstable health problems and several specific medical conditions.
This study looks at how quickly older adults lose muscle strength and mass while hospitalized for a sudden medical illness. It may help find ways to prevent or treat this muscle loss.
This study looks at how muscle loss (sarcopenia) might affect side effects from cancer treatments. If you are starting a new cancer treatment, a CT scan before treatment can help doctors predict your risk of side effects.
Hear when a new Multiple sclerosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.